M
Maia N. Pavlovic
Researcher at Harvard University
Publications - 4
Citations - 1574
Maia N. Pavlovic is an academic researcher from Harvard University. The author has contributed to research in topics: Humoral immunity & Neutralization. The author has an hindex of 4, co-authored 4 publications receiving 538 citations.
Papers
More filters
Journal ArticleDOI
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Wilfredo F. Garcia-Beltran,Wilfredo F. Garcia-Beltran,Evan C. Lam,Kerri St. Denis,Adam Nitido,Zeidy H. Garcia,Blake M. Hauser,Jared Feldman,Maia N. Pavlovic,David Gregory,Mark C. Poznansky,Alex Sigal,Alex Sigal,Aaron G. Schmidt,A. John Iafrate,Vivek Naranbhai,Vivek Naranbhai,Alejandro B. Balazs +17 more
TL;DR: In this article, the authors evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2.
Posted ContentDOI
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Wilfredo F. Garcia-Beltran,Wilfredo F. Garcia-Beltran,Evan C. Lam,Kerri St. Denis,Adam Nitido,Zeidy H. Garcia,Blake M. Hauser,Jared Feldman,Maia N. Pavlovic,David Gregory,Mark C. Poznansky,Alex Sigal,Alex Sigal,Aaron G. Schmidt,A. John Iafrate,Vivek Naranbhai,Alejandro B. Balazs +16 more
TL;DR: In this article, the authors evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against 10 globally circulating strains of SARS-CoV-2.
Journal ArticleDOI
Erratum: Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (Cell (2021) 184(9) (2372–2383.e9), (S0092867421002981), (10.1016/j.cell.2021.03.013))
Wilfredo F. Garcia-Beltran,Wilfredo F. Garcia-Beltran,Evan C. Lam,Kerri St. Denis,Adam Nitido,Zeidy H. Garcia,Blake M. Hauser,Jared Feldman,Maia N. Pavlovic,David Gregory,Mark C. Poznansky,Alex Sigal,Aaron G. Schmidt,Aaron G. Schmidt,A. John Iafrate,Vivek Naranbhai,Alejandro B. Balazs +16 more
Posted ContentDOI
Immunogenicity of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines
Vivek Naranbhai,Wilfredo F. Garcia-Beltran,Christhian Berrios Mairena,Julia Thierauf,Christina C. Chang,Grace Kirkpatrick,Maristela L. Onozato,Ju Cheng,Kerri St. Denis,Evan C. Lam,Clarety Kaseke,Rhoda Tano-Menka,Diane Yang,Maia N. Pavlovic,Wendy Yang,Alexander Kui,Tyler E. Miller,Michael G Astudillo,Jennifer E Cahill,Anand S. Dighe,David Gregory,Mark C. Poznansky,Gaurav D. Gaiha,Alejandro B. Balazs,Anthony J. Iafrate +24 more
TL;DR: In this paper, the authors compared the immunogenicity of mRNA-1273, BNT-162b2 or Ad26.COV2.S in ambulatory adults in Massachusetts, USA.